אירינוטקן " אבווה, 20 מ"ג / מ"ל ישראל - עברית - Ministry of Health

אירינוטקן " אבווה, 20 מ"ג / מ"ל

pharmalogic ltd - irinotecan hydrochloride trihydrate 20 mg / 1 ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.

"single use drapes and gowns,wound care,bandages" ישראל - עברית - Ministry of Health

"single use drapes and gowns,wound care,bandages"

"אורטה מדיקל בע""מ" - אחות - כיסויים חד פעמיים לכלל בית החולים ומרפאות

single use drapes and gowns,wound care,bandages ישראל - עברית - Ministry of Health

single use drapes and gowns,wound care,bandages

אורטה מדיקל בע"מ - אחות - כיסויים חד פעמיים לכלל בית החולים ומרפאות

SINGLE USE SURGICAL INSTRUMENTS ישראל - עברית - Ministry of Health

single use surgical instruments

עינת מדיקל סוכנויות בע"מ - רופא - לניתוחים כללים ולניתוחי עיניים

Single use Laparoscopic products and single use products ישראל - עברית - Ministry of Health

single use laparoscopic products and single use products

נובוגולד בע"מ - אחות - מכשור לפרסקופי ואביזרים לחדר ניתוח חד פעמיים

אוונקס תמיסה להזרקה ישראל - עברית - Ministry of Health

אוונקס תמיסה להזרקה

medison pharma ltd - interferon beta 1a - תמיסה להזרקה - interferon beta 1a 30 mcg / 0.5 ml - interferon beta-1a - interferon beta-1a - treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of mri abnormalities characteristic of ms and if they are determined to be at high risk of developing clinically definite multiple sclerosis. safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.